TotalMarketCap

Pasithea Therapeutics

KTTANasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$16.811 M

$0.50 -5.08%

Close of 6 Nov 2026

As of 6 Nov 2026, Pasithea Therapeutics (KTTA) has a market capitalization of $16.8M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$20.4M

Loss-making

Shares outstanding

33,414,448

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #390Akari TherapeuticsAKTX$17.5M
  2. #391Context TherapeuticsCNTX$17.2M
  3. #392Pasithea TherapeuticsKTTA$16.8M
  4. #393NewcelXNCEL$16.4M
  5. #394Psyence BiomedicalPBM$15.6M

What if Pasithea Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$845,049.83

Per share 1,679,686× higher

Bitcoin $1.53T

$45,724.17

Per share 90,885× higher

Apple $5.02T

$150,108.20

Per share 298,367× higher

Or at a round number

$50.0M$100.0M$200.0M$500.0M

Where these numbers come from

Share counts and financials for Pasithea Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.